CSL · 1 month ago
Marketing Summer Internship – 10 Weeks Direct-to-Consumer
Americas, US-PA, King of Prussia, CSL Behring
Internship
Onsite
InternCSL Behring is a global biotherapeutics leader driven by our promise to save lives. As a Marketing Intern supporting the Direct-to-Consumer Marketing team, you will gain hands-on experience helping shape the future of consumer engagement in rare disease, with exposure to social listening, consumer insights, and omnichannel marketing strategy.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Conduct social listening across patient forums, advocacy groups, and social platforms to identify themes related to trust, education, and engagement
Analyze conversations for sentiment and key insights, including education gaps, emotional support needs, and treatment barriers
Research consumer expectations and trusted brands outside of pharma to understand loyalty drivers, personalization, and authenticity
Compare social listening findings with broader consumer marketing trends
Support the development of actionable insights to inform CSL Behring’s omnichannel and influencer strategies
Synthesize findings into a final insights report and strategic recommendations
Present outcomes and recommendations to senior marketing leadership
Qualification
Required
Rising junior or senior pursuing a bachelor's degree in Marketing, Business, Communications, or a related field
Strong analytical, research, and critical‑thinking skills
Interest in healthcare marketing, consumer behavior, and digital innovation
Excellent written, verbal, and presentation skills
Curious, creative, and eager to learn in a collaborative environment
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Founded in 1916
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Leadership Team
Jeffrey Ball
Chief Sustainability Officer
Joy Linton
Strategic Advisor
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase